The HealthTech Signal
Laza Medical logo

Laza Medical

AI-powered robotic ultrasound imaging for structural heart, electrophysiology and diagnostic procedures.

lazamedical.com

What they do

Laza Medical is building an intelligent ultrasound imaging system for structural heart, electrophysiology and diagnostic procedures: AI-powered real-time 3D heart modeling, echo-based procedural guidance and robotic probe control. On November 4, 2026 it announced up to $160 million in structured Series B financing led by GE HealthCare. The Laza Medical System is under development and not approved for commercial sale in any geography; the company says a first-in-human clinical study took place in 2025.

Source announcement

People in this update

  • Amr SalahiehFounder and Board Chairman; founder of ShifamedSource

The record

Vertical
Cardiovascular
Sub-segment
AI and robotic cardiac imaging
Product type
Medical device
Stage
Series B; Shifamed portfolio company
Headquarters
Los Gatos, California, United States
Region
North America
Founded
Not disclosed
Total funding
Undisclosed

Notable investors: GE HealthCare, Unorthodox Ventures, PA MedTech, AMED.

Also in Cardiovascular

See the Cardiovascular market map

Related on The Signal

Keep exploring